Summary
1. The pulmonary hyaline membranes of the adult are much more common than admitted so far. In 42 of 833 autopsies (5%) performed after the 7th day of life (end of the perinatal period), more or less extensive hyaline membranes have been observed in one or more lobes.
2. Disseminated intravascular microthrombi—a morphological equivalent of a generalised hypercoagulability—were found in 71 of 93 autopsies. In most of these, no relation between the basic disease and the frequency of hyaline membranes could be established. However, in 72 of 93 cases, the formation of hyaline membranes was preceded by a prolonged shock of traumatic, postoperative, cardiogenic, allergic-hyperergic, septic, endotoxic or infectious-toxic origin or by an operation with extracorporal circulation. The remaining cases showed malignant neoplasms (carcinoma of the pancreas, colon, stomach, and prostate gland, malignant teratoid, multiform glioblastoma, promyelocytic leukemia, liver cirrhosis, congenital cyanotic heart diseases and in one case a premature separation of the placenta.
3. It is assumed that a generalised activation of coagulation with formation of circulating fibrin monomeres is the common pathogenic principle to all cases with pulmonary hyaline membranes. The extravasation of the plasmatic fibrin monomeres into the alveoli and into the terminal bronchioles and their extravascular polymerisation lead to the formation of the pulmonary hyaline membranes. The frequency of hyaline membranes in the adult is due to the frequency of a generalised plasmatic hypercoagulability which is associated with cases of shock (of different etiology), malignant tumors, promyelocytic leukemias, congenital cyanotic heart disease, liver cirrhosis and subpartual bleeding complications at birth.
4. Alike pulmonary atelectases, pulmonary hyaline membranes are the morphological equivalent of a syndrome of respiratory distress in the adult, an acute respiratory insufficiency due to circulatory shock. The relationships between shock, hyaline membranes, inhibition and/or disturbance of the synthesis of the surfactant and respiratory insufficiency are discussed.
Zusammenfassung
1. Pulmonale hyaline Membranen des Erwachsenen sind häufiger, als bislang vermutet wurde. 42 von 833 Obduktionsfällen (5%) zeigten jenseits des 7. postnatalen Lebenstages (Ende der Perinatalperiode) mehr oder weniger ausgedehnte hyaline Membranen in einem oder in mehreren Lungenlappen.
2. Bei 71 von 93 Obduktionsfällen mit pulmonalen hyalinen Membranen ließen sich disseminierte intravasale Mikrothromben als morphologische Äquivalente einer generalisierten plasmatischen Hypercoagulabilität nachweisen. Beziehungen zwischen der Grundkrankheit der 93 Obduktionsfälle und der Häufigkeit pulmonaler hyaliner Membranen ließen sich nicht erkennen. Bei 72 der 93 Obduktionsfälle ging der Ausbildung der pulmonalen hyalinen Membranen jedoch ein protrahierter (traumatischer, postoperativer, kardiogener, allergisch-hyperergischer, septischer bzw. bakteriell-endotoxischer und infektiös-toxischer) Schock oder eine Operation im extracorporalen Kreislauf voraus, in den übrigen Fällen fanden sich maligne Tumoren (Pankreas-, Magen-, Colon- und Prostatacarcinome, malignes Teratoid, Glioblastoma multiforme), Promyelocytenleukämien, Lebercirrhosen, cyanotischen Herzfehlern sowie in einem Fall eine vorzeitige Lösung der Placenta.
3. Als gemeinsames pathogenetisches Prinzip aller Obduktionsfälle mit pulmonalen hyalinen Membranen muß eine generalisierte Aktivierung der Gerinnung mit Ausbildung intravasal zirkulierender Fibrinmonomere gelten. Die Extravasation der plasmatischen Fibrinmonomere im Bereich der Alveolen und Bronchioli terminales und ihre extravasale Polymerisation führt zur Ausbildung der pulmonalen hyalinen Membranen. Die Häufigkeit der hyalinen Membranen des Erwachsenen resultiert aus der Häufigkeit einer generalisierten plasmatischen Hypercoagulabilität bei Schockfällen verschiedenster Ätiologie, bei malignen Tumoren, Promyclocytenleukämien, cyanotischen Herzfehlern, Lebercirrhosen und subpartualen Geburtskomplikationen.
4. Pulmonale hyaline Membranen sind wie pulmonale Atelektasen morphologisches Äquivalent eines im Gefolge eines Kreislaufschocks auftretenden Atemnotsyndroms der Erwachsenen, einer akuten respiratorischen Insuffizienz. Die Wechselbeziehungen zwischen Schock, hyalinen Membranen, Hemmung und Synthesestörung des Anti-Atelektase-Faktors und respiratorischer Insuffizienz werden diskutiert.
Similar content being viewed by others
Literatur
Alkjaersig, N., Fletcher, A. P., Sherry, S.: Pathogenesis of the coagulation defect developing during plasma proteolytic (fibrinolytic) states. II. The significance, mechanism and consequence of defective fibrin polymerization. J. clin. Invest.41, 917 (1962).
Beller, F. K., Mitchell, P., Gorstein, F.: Fibrin deposition in the rabbit by protease inhibitors. Thrombos. Diathes. haemorrh. (Stuttg.)17, 429 (1967).
Bleyl, U.: Zur disseminierten intravasalen Gerinnung im fetalen Organismus. Verhdlg. Deutsche Arb. gemeinschaft f. Blutgerinnungsforschung, 13. Tgg Deidesheim 26.–28. 3. 1969. Stuttgart-New York: F. K. Schattauer 1969 (im Druck).
—— Vergleichende Untersuchungen an Erwachsenen und Neugeborenen zur Entstehung pulmonaler hyaliner Membranen. Verh. dtsch. Ges. Path.54, 340 (1970).
-- Morphologische Untersuchungen zur Pathogenese pulmonaler hyaliner Membranen. Tgg deutscher Pathol. Wiesbaden 10.–12. 10. 1969. Zbl. allg. Path. path. Anat. (1970) (im Druck).
—— Büsing, C. M.: Disseminierte intravasale Gerinnung und perinataler Schock. Verh. dtsch. Ges. Path.53, 495 (1969).
—— —— Kreislaufschock und disseminierte intravasale Gerinnung bei intrauterinem und perinatalem Fruchttod. Klin. Wschr.48, 13 (1970).
—— —— Krempien, B. Pulmonale hyaline Membranen und perinataler Kreislaufschock. Virchows Arch. Abt. A Path. Anat.348, 187 (1969).
—— Höpker, W. W.: Disseminierte intravasale Gerinnung und pulmonale hyaline Membranen bei connatalen cyanotischen Herzfehlern. Virchows Arch. Abt. A Path. Anat.350, 225 (1970).
—— Kuhn, W., Graeff, H.: Reticulo-endotheliale Clearance intravasaler Fibrinmonomere in der Milz. Thrombos. Diathes. haemorrh. (Stuttg.)22, 87 (1969).
—— Wanke, M.: Morphologische und gerinnungsanalytische Untersuchungen zum postpankreatitischen Schock. In: Neue Aspekte der Trasylol-Therapie, S. 111. Stuttgart: F. K. Schattauer, 1969.
Boggust, W. A., O'Brien, D. J., O'Meara, R. A. Q., Thornes, R. D.: The coagulative factors of normal human and human cancer tissue. Irish J. med. Sci.447, 131 (1963).
Buckingham, S., Sommers, S. C.: Pulmonary hyaline membranes: a study of the infant disease and experimental hyaline membranes induced pharmacologically. Amer. J. Dis. Child.99, 216–227 (1960).
Coon, W. W., Hodgson, P. E.: Fibrinolysis in surgery patients I. Possible relationship to a hemorrhagic diathesis. Surg. Gynec. Obstet.95, 717–724 (1952).
Crane, J. J., Ware, A. G., Hamilton, J.: Spontaneous afibrinogenaemia in cancer of prostate: Report of two cases. J. Urol. (Baltimore)73, 379 (1955).
Creveld, S. van: Hemorrhagic diathesis in congenital heart disease. Influence of operation under hypothermia and of whole blood transfusions. Ann. paediat. (Basel)190, 342 (1958).
Crowell, J. W., Sharpe, G. P., Lambright, R. L., Read, W. S.: The mechanism of death after resuscitation following acute circulatory failure. Surgery38, 696–702 (1955).
Dennis, L. H., Stewart, J. L., Conrad, M. E.: Heparin treatment of hemorrhagic diathesis in cyanotic congenital heart disease. Lancet1967 I, 1088–1089 (1967).
Deykin, D., Cochios, F., DeCamp, G., Lopez, A.: Hepatic removal of activated factor X by the perfused rabbit liver. Amer. J. Physiol.214, 414 (1968).
Didisheim, P., Bowie, E. J., Owen, C. A.: Intravascular coagulation fibrinolysis (ICF) syndrome and malignancy: historical review and report of two cases with metastatic carcinoid and with myelomonocytic leukemia. In: Disseminated intravascular coagulation (E. F. Mammen, G. F. Anderson, M. I. Barnhart, eds.). Stuttgart-New York: F. K. Schattauer, 1969.
—— Thrombold, J. S., Vandervoort, R. L. E., Mibashan, R. S.: Acute promyelocytic leukemia with fibrinogen and factor V deficiencies. Blood23, 717 (1964).
Edson, J. R., Krivit, W., White, J. G., Sharp, H. L.: Intravascular coagulation in acute stern cell leukemia successfully treated with heparin. J. Pediat.71, 342 (1967).
Fletcher, A. P., Biedermann, O., Moore, D., Alkjaersig, N., Sherry, S.: Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: its cause and consequences. J. clin. Invest.43, 681 (1964).
Fono, R., Miltenyi, M., Forral, G., Büki, B.: Thrombelastographische Untersuchungen an hypernatriämischen Kindern mit angeborenen Herzfehlern. Ann. paediat. (Basel)200, 271 (1963).
Frick, P. G.: Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer. Acta haemat. (Basel)16, 11 (1956).
Gagel, Ch., Linder, M., Müller-Berghaus, G., Lasch, H. G.: Virus infection and blood coagulation. Thrombos. Diathes. haemorrh. (Stuttg.)23, 1–11 (1970).
Gastpar, H.: Metastasierung und Blutgerinnung. In: Fibrinstabilisierender Faktor, Struktur des Blutgerinnsels, Krebs und Blutgerinnung Verhandl. Deutsche Arb. gemeinschaft. f. Blutgerinnungsforschung, 11. Tagg Wien 14.–15. 4. 1967. Stuttgart: F. K. Schattauer, 1968.
Girolami, A., Cliffton, E. E.: Fibrinolytic and proteolytic activity in acute and chronic leukemia. Amer. J. med. Sci.251, 638 (1966).
Glück, L., Kulovich, M. V., Motoyama, E. K., Smits, H. L., Eidelman, A., Khazin, A., Cook, C. D.: A biochemical basis for the respiratory distress syndrome. Pediatr. Res.1, 290 (1967).
Godal, H. C., Abildgaard, U.: The symptomatic effect of anticoagulant therapy in defibrination syndrome associated with demonstrable fibrin in plasma: A case report. Acta med. scand.174, 311 (1963).
Goldschmidt, B.: Untersuchung der Gerinnungsfaktoren an cyanotischen Kindern mit angeborenen Herzfehlern. Ann. paediat. (Basel)207, 321 (1966).
Halpern, B., Milliez, P., Lagrue, G., Fray, A., Morard, J. C.: Protective action of heparin in experimental immune nephritis. Nature (Lond.)205, 257 (1965).
Happs, H. C., Wissler, R. W.: Uremie pneumonitis. Amer. J. Path.31, 261–273 (1955).
Hardaway, R. M.: Syndromes of disseminated intravascular coagulation. Springfield (III.): Ch. C. Thomas, 1966.
Heal, F. C., Kent, G.: Purpura fulminans with afibrinogenaemia, Canad. med. Ass. J.69, 367–370 (1953).
Henry, J. N.: The effect of shock on pulmonary alveolar surfactant. Its role in refractory respiratory insufficiency of the critically ill or severely injured patient. J. Trauma8, 756–770 (1968).
—— McArdle, A. H., Scott, H. J., Gurd, F. N.: A study of the acute and chronic respiratory pathophysiology of hemorrhagic shock. J. thorac. cardiovasc. Surg.54, 666–681 (1967).
Herrmann, R. E., Ogura, G. I., Johnson, E. S., Tole, H. W., Jr., White, W. C.: Respiratory deaths associated with asian influenza epidemie. J. Amer. med. Ass.166, 467–471 (1958).
Hillestad, L. K.: Acute promyclocytic leukemia. Acta med. scand.159, 189 (1957).
Hörder, M. H.: Consumption coagulopathy in liver cirrhosis In: Disseminated intravascular coagulation (E. F. Mammen, G. F. Anderson, M. I. Barnhart, eds.). Stuttgart-New York: F. K. Schattauer, 1969.
Humair, L., Kwaan, H. C., Potter, E. V.: The role of fibrinogen in renal disease. II. Effect of anticoagulants and urokinase on experimental lesions in mice. J. Lab. clin. Med.74, 72 (1969).
—— Potter, E. V., Kwaan, H. C.: The role of fibrinogen in renal disease. I. Production of experimental lesions in mice. J. Lab. clin. Med.74, 60 (1969).
Huth, K., Brand, K.: Ungewöhnlicher Verlauf einer Promyelocytenleukämie. Klin. Wschr.44, 616 (1966).
Johnson, A. J., Merskey, C.: Diagnosis of diffuse intravascular clotting: its relation to secondary fibrinolysis and treatment with heparin. Thrombos. Diathes. haemorrh. (Stuttg.), Suppl.20, 161 (1966).
Kincaid-Smith, P., Saker, B. M., Fairley, K. F.: Anticoagulants in “irreversible” acute renal failure. Lancet1968 II, 1360–1363.
Kleinmaier, H., Goergen, K., Lasch, H. G., Krecke, H.-J., Bohle, A.: Untersuchungen zur Frage der Gerinnungsstörung beim Sanarelli-Shwartzman-Phänomen (sog. generalisiertes Shwartzman-Phänomen). Z. ges. exp. Med.132, 275 (1959).
Kleinerman, J.: Effects of heparin on experimental nephritis in rabbits. Lab. Invest.3, 495 (1954).
Knauer, H.: Das Krankheitsbild der Purpura fulminans. Jahrb. Kinderheilk.118, 1–16 (1928).
Kontras, S. B., Birak, H. D., Newton, W. A., Jr.: Hematologic abnormalities in children with congenital heart disease. J. Amer. med. Ass.195, 611–615 (1966).
Korst, D. R., Kratochvil, C. H.: Cryofibrinogen in case of lung neoplasm associated with thrombophlebitis migrans. Blood10, 945 (1955).
Kümmer, H., Gurtner, H. P., Bucher, U.: Thrombozytopenie bei chronischem Cor pulmonale und zyanotischen Herzvitien. Schweiz. med. Wschr.94, 1334 (1964).
Kuhn, W., Graeff, H.: Verbrauchskoagulopathie bei geburtshilflichen Blutungen. Geburtsh. u. Frauenheilk.26, 913 (1966).
Landor, H.: A case of acute hemorrhagic leucoencephalitis (Hurst) complicating varicella. J. Path. Bact.70, 157–165 (1955).
Lasch, H. G.: Therapeutic aspects of disseminated intravascular coagulation. In: Disseminated intravascular coagulation (E. F. Mammen, G. F. Anderson, M. I. Barnhart, eds.). Stuttgart-New York: F. K. Schattauer, 1969.
—— Heene, D. L., Huth, K., Sandritter, W.: Pathophysiology, clinical manifestations and therapy of consumption coagulopathy („Verbrauchskoagulopathie“). Amer. J. Cardiol.20, 381–391 (1967).
—— Krecke, H.-J., Rodriguez-Erdmann, F., Sessner, H. H., Schütterle, G.: Verbrauchskoagulopathie (Pathogenese und Therapie). Folia haemat. (Frankfurt), N. F.1, 325 (1961).
—— Roka, L.: Zur Prothrombinbildung in der Leber. Hoppe Seylers Z. physiol. Chem.294, 30 (1953).
Latallo, Z., Fletcher, A. P., Alkjaersig, N., Sherry, S.: Inhibition of fibrin polymerization by fibrinogen proteolysis products. Amer. J. Physiol.202, 681 (1962).
Lec, L.: Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J. exp. Med.115, 1065 (1962).
—— Antigen-antibody reaction in the pathogenesis of bilateral renal cortical necrosis. J. exp. Med.117, 365 (1963).
—— Prose, P. H., Cohen, M. H.: The role of the reticulo-endothelial system in diffuse, low grade intravascular coagulation. Thrombos. Diathes. haemorrh. (Stuttg.), Suppl.20, 87–95 (1966).
Lendrum, A. C., Fraser, D. S., Seidders, W., Henderson, R.: Studies on the character and staining of fibrin. J. clin. Path.15, 401 (1962).
Lipinski, B., Wegrzynowicz, Z., Budzinski, A. H., Kopec, M., Latallo, Z. S., Kowalski, E.: Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thrombos. Diathes. haemorrh. (Stuttg.)17, 65–77 (1967).
Marder, V. J., Shulman, N. R.: High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. J. biol. Chem.244, 2120 (1969).
—— Shulman, N. R., Carroll, W. R.: High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunologic characterization. J. biol. Chem.244, 2111 (1969).
Margaretten, W., Zunker, H. O., McKay, D. G.: Production of the generalized Shwartzman reaction in pregnant rats by intravenous infusion of thrombin. J. Lab. Invest.13, 552 (1964).
Martin, Y. M., Soloway, H. B., Simmons, R. I.: Pathologic anatomy of the lungs following shock and trauma. J. Trauma8, 687–698 (1968).
McKay, D. G.: Disseminated intravascular coagulation. An intermediary mechanism of disease. New York-Evanston-London: Hoeber Medical Div., Harper and Row Publishers, 1965.
—— Mansell, H., Hertig, A. T.: Carcinoma of the body of the pancreas with fibrin thrombosis and fibrinogenopenia. Cancer (Philad.)6, 862 (1953).
—— Margaretten, W.: Disseminated intravascular coagulation in virus disease. Arch. intern. Med.120, 129 (1967).
—— Wahle, G. H., Jr.: Disseminated thrombosis in colon cancer. Cancer (Philad.)8, 970 (1955).
Merskey, C., Johnson, A. J., Pert, J. H., Wohl, H.: Pathogenesis of fibrinolysis in defibrination syndrome: effect of heparin administration. Blood24, 701 (1964).
Michael, A. F., Drummond, K. N., Good, R. A., Vernier, R. L.: Acute poststreptococcal glomerulonephritis: Immune deposits disease. J. clin. Invest.45, 237 (1966).
Miller, S. P., Davison, T.: Defibrination syndrome in cancer: treatment with heparin. N. Y. med. J.67, 452 (1967).
Montgomery, R. R., Olafson, M.: Waterhouse-Friderichsen syndrome in varicella. Ann. intern. Med.53, 576 (1960).
Moolten, S. E.: Pulmonary fibrosis in rheumatic heart disease. Amer. J. Med.33, 421 (1962).
Niewiarowski, S., Kowalski, E.: Un nouvel anticoagulant dérivé du fibrinogène. Rev. Hémat.13, 320 (1958).
Ober, W. E., Reid, D. E., Ronney, S. L., Merrill, D. P.: Renal lesions and acute renal failure in pregnancy. Amer. J. Med.21, 781 (1956).
O'Meara, R. A. Q.: Coagulative properties of cancer. Irish J. med. Sci.394, 474 (1958).
—— The growth pattern of carcinomas. Arch. De Vecchi Anat. pat.31, 365 (1960).
—— Fibrin formation and tumour growth In: Fibrinstabilisierender Faktor, Struktur des Blutgerinnsels, Krebs und Blutgerinnung. Verhandl. Deutsche Arbeitsgemein. f. Blutgerinnungsf., 11. Tagg Wien 14.–15. 4. 1967. Stuttgart: F. K. Schattauer, 1968.
Owen, C. A., Jr., Oels, H. C., Bowie, E. J. W., Didisheim, P., Thompson, J. H., Jr.: Chronic intravascular coagulation (ICF) syndrome. In: Disseminated intravascular coagulation (E. F. Mammen, G. F. Anderson, M. I. Barnhart, eds.). Stuttgart-New York: F. K. Schattauer, 1969.
Paul, M. H., Currimbhoy, J., Miller, R. A., Schulman, I.: Thrombocytopenie in cyanotic congenital heart disease. Amer. J. Dis. Child.102, 597 (1961).
Pittman, G. R., Senhauer, D. A., Lowney, J. F.: Acute promyelocytic leukemia: a report of 3 autopsied cases. Amer. J. clin. Path.46, 214 (1966).
Quick, A. J.: Hemorrhagic disease, p. 261. Philadelphia: Lea and Febiger, 1957.
Rapaport, S. I., Chapman, C. G.: Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. Amer. J. Med.27, 144 (1959).
Remmele, W., Harms, D.: Zur pathologischen Anatomie des Kreislaufschocks beim Menschen. I. Mikrothrombose der peripheren Blutgefäße. Klin. Wschr.46, 352 (1968).
Rock, J. A., Baude, A. I., Morau, Th. J.: Asian influenza and mitral stenosis. J. Amer. med. Ass.166, 1467 (1958).
Ryder, R. J. W.: Promyelocytic leukaemia and hypofibrinogenaemia. Acta haemat. (Basel)35, 181 (1966).
Schenck, W., Kollmann, W., Kuenzer, W.: Untersuchungen zur Blutgerinnung bei Kindern mit angeborenen Herzfehlern. Z. Kinderheilk.100, 213 (1967).
Schneider, Ch. L.: “Fibrin embolism” (disseminated intravascular coagultion) with defibrination as one of the end results during pregnancy placenta abruptio. Surg. Gynec. Obstet.92, 27 (1951).
—— Defibrination syndrome. Clin. Obstet. Gynec.7, 339 (1964).
Sinapius, D.: Zur Beurteilung hyaliner Membranen in den Lungen Neugeborener. Z. Kinderheilk.84, 496 (1960).
Soto, P. J., Broun, G. O., Wyott, J. P.: Asian influenzal pneumonitis, a structural and virologic analysis. Amer. J. Med.27, 18 (1959).
Spaet, Th. H., Horowitz, H. I., Zucker-Franklin, D., Cintron, J., Biezenski, J. J.: Reticuloendothelial clearance of blood thromboplastin by rats. Blood17, 196 (1961).
Stefanini, M., Giammalvo, J. T., Karaca, M.: Demonstration of two additional mechanisms in the pathogenesis of the syndrome of acquired fibrinogenopenia. Amer. J. med. Sci.246, 58 (1963).
Straub, P. W., Riedler, G., Frick, P. G.: Hypofibrinogenopenia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin. J. clin. Path.20, 152 (1967).
Streiff, F., Peters, A., Royer, R., Alexandre, P.: Syndrome de défibrination au cours d'une leucose à promyélocytes: Problèmes physiopathologiques. Nouv. Rev. franc. Hémat.6, 712 (1966).
Swan, H. T., Wood, K. F., Daniel, O.: Dangerous bleeding associated with carcinoma of prostate. Brit. med. J.1957 I, 495.
Taylor, F. B., Jr., Abrams, M. E.: Inhibition of clot lysis by a surface active lipoprotein from lung and inhibition of its surface activity by fibrinogen. Physiologist7, 269 (1964).
—— —— Effect of surface active lipoprotein on clotting and fibrinolysis, and of fibrinogen on surface tension of surface active lipoprotein. With a hypothesis on the pathogenesis of pulmonary atelectasis and hyaline membrane in respiratory distress syndrome of the newborn. Amer. J. Med.40, 346 (1966).
Theiss, W., Graeff, H., Bleyl, U., Immich, H., Kuhn, W.: Reversible Stadien intravaskulärer Gerinnung und ihre Auswirkungen auf Nierenfunktion und Urokinaseausscheidung. Thrombos. Diathes. haemorrh. (Stuttg.)23, 369 (1970).
Triantaphyllopoulos, D. C.: Preliminary report on the anticoagulant properties of incubated fibrinogen. Proceed. 11th Annual Meeting West. Group, Div. Med. Res. Nat. Res. Council of Canada11, 21 (1957).
—— Anticoagulant effect of incubated fibrinogen. Canad. J. Biochem.36, 249 (1958).
Tytgat, G. N., Collen, D. J., Vreker, R. A. de: La diathèse hémorrhagique en cas de cirrhose du foie. Nouv. Rev. franc. Hémat.8, 123 (1968).
Vassalli, P., McCluskey, R. T.: The pathogenetic role of fibrin deposition in immunologically induced glomerulonephritis. Ann. N. Y. Acad. Sci.116, 1052 (1964).
—— —— The pathogenetic role of the coagulation process in rabbit Masugi nephritis. Amer. J. Path.45, 553 (1964).
Author information
Authors and Affiliations
Additional information
Mit Unterstützung durch die Deutsche Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Bleyl, U., Heilmann, K. & Adler, D. Generalisierte plasmatische Hypercoagulabilität und pulmonale hyaline Membranen beim Erwachsenen. Klin Wochenschr 49, 71–81 (1971). https://doi.org/10.1007/BF01497303
Issue Date:
DOI: https://doi.org/10.1007/BF01497303